Shizuru Judith Anne 4
4 · Jasper Therapeutics, Inc. · Filed Mar 23, 2022
Insider Transaction Report
Form 4
Shizuru Judith Anne
Director
Transactions
- Award
Stock Option (right to buy)
2022-03-21+78,045→ 78,045 totalExercise: $3.54Exp: 2032-03-21→ Voting Common Stock (78,045 underlying)
Footnotes (1)
- [F1]1/3rd of the shares subject to the option shall vest on December 7, 2022, and 1/3rd of the shares subject to the option shall vest on each anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.